These results hold significant relevance since elevated levels of IL-6 have been identified as the primary biomarker associated with pulmonary bacterial infections in chronic myeloid leukemia (CML) patients [31]. This evidence concerns the gene IL6 and chronic myelogenous leukemia, BCR-ABL1 positive.